FUDR | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

70 results for “FUDR”

Trials

View all 41 →

Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLM

92 participants · First posted Apr 18, 2018

FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM

92 participants · First posted Sep 19, 2018

Hepatic Arterial Infusion Chemotherapy in Patients With Inoperable Colorectal Cancer Liver Metastasis

200 participants · First posted Aug 14, 2026

Drugs

View all 23 →

3'-O-BOBA-FUDR

Floxuridine

Manufacturer: App pharmaceuticals llc, Bedford laboratories div ben venue laboratories inc +1 more

Conditions: Stage 4 gastrointestinal adenocarcinoma

<dd class="col-xl-8 col-md-9 col-sm-8">C₉H₁₁FN₂O₅</dd> · Rx

Investigational

Fosifloxuridine nafalbenamide

C₂₉H₂₉FN₃O₉P

Organizations

FREUNDESKREIS FUR INTERNATIONALE TUBERKULOSEHILFE E.V (FIT)

Vietnam

News

Regional Chemotherapy Shows Promise in Treating Colorectal Cancer Metastatic to the Liver

Regional Chemotherapy for Colorectal Liver Metastases: A Retrospective Study

Sirtex Medical's SIR-Spheres Y-90 Resin Microspheres Receive FDA Approval for Unresectable Hepatocellular Carcinoma

Page 1 of 7